COVID-19 Vaccination—Becoming Part of the New Normal
Author:
Affiliation:
1. US Food and Drug Administration, Silver Spring, Maryland
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/articlepdf/2792030/jama_marks_2022_vp_220047_1652453114.53165.pdf
Reference8 articles.
1. Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States.;Gupta;Health Aff (Millwood),2021
2. Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance: VISION Network, 10 states, August 2021-January 2022.;Thompson;MMWR Morb Mortal Wkly Rep,2022
3. Protection by a fourth dose of BNT162b2 against Omicron in Israel.;Bar-On;N Engl J Med
4. Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance—VISION Network, 10 states, August 2021-January 2022.;Ferdinands;MMWR Morb Mortal Wkly Rep,2022
5. Post-acute COVID-19 syndrome.;Nalbandian;Nat Med,2021
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. One-size fits all? Evaluating group differences in an integrated social cognition model to understand COVID-19 vaccine intention and uptake;Social Science & Medicine;2024-05
2. COVID-19 vaccines: history of the pandemic’s great scientific success and flawed policy implementation;Monash Bioethics Review;2024-03-09
3. Vaccinating against a Novel Pathogen: A Critical Review of COVID-19 Vaccine Effectiveness Evidence;Microorganisms;2023-12-31
4. Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021–February 2022, VISION Network: a retrospective cohort study;The Lancet Regional Health - Americas;2023-07
5. Factors Affecting the Public Intention to Repeat the COVID-19 Vaccination: Implications for Vaccine Communication;Healthcare;2023-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3